pmid string | title string | abstract string | text string | entities list | relations list |
|---|---|---|---|---|---|
17512723 | RDH12, a retinol dehydrogenase causing Leber's congenital amaurosis, is also involved in steroid metabolism. | Three retinol dehydrogenases (RDHs) were tested for steroid converting abilities: human and murine RDH 12 and human RDH13. RDH12 is involved in retinal degeneration in Leber's congenital amaurosis (LCA). We show that murine Rdh12 and human RDH13 do not reveal activity towards the checked steroids, but that human type 1... | RDH12, a retinol dehydrogenase causing Leber's congenital amaurosis, is also involved in steroid metabolism. Three retinol dehydrogenases (RDHs) were tested for steroid converting abilities: human and murine RDH 12 and human RDH13. RDH12 is involved in retinal degeneration in Leber's congenital amaurosis (LCA). We show... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "androstanediol",
"start": 466,
"end": 480
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "retinol",
"start": 115,
"end": 122
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "retinol",
"start": 9,
"end": 16
},... | [
{
"type": "PRODUCT-OF",
"arg1": "T1",
"arg2": "T9"
}
] |
23557993 | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. | Curcuma comosa Roxb. is ginger-family plant used to relieve menopausal symptoms. Previous work showed that C. comosa extracts protect mice from ovariectomy-induced osteopenia with minimal effects on reproductive organs, and identified the diarylheptanoid (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol (DPHD) as the major ... | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. Curcuma comosa Roxb. is ginger-family plant used to relieve menopausal symptoms. Previous work showed that C. comosa extracts protect mice from ovariectomy-induced osteop... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "DPHD",
"start": 1259,
"end": 1263
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "estrogen",
"start": 1287,
"end": 1295
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "ICI182780",
"start": 1316,
"end": 1325
... | [
{
"type": "ANTAGONIST",
"arg1": "T3",
"arg2": "T24"
},
{
"type": "ACTIVATOR",
"arg1": "T18",
"arg2": "T31"
},
{
"type": "ACTIVATOR",
"arg1": "T1",
"arg2": "T24"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T4",
"arg2": "T25"
},
{
"type": "INDIRECT... |
23161873 | The role of the carbohydrate response element-binding protein in male fructose-fed rats. | By 2030, nearly half of Americans will have nonalcoholic fatty liver disease. In part, this epidemic is fueled by the increasing consumption of caloric sweeteners coupled with an innate capacity to convert sugar into fat via hepatic de novo lipogenesis. In addition to serving as substrates, monosaccharides also increas... | The role of the carbohydrate response element-binding protein in male fructose-fed rats. By 2030, nearly half of Americans will have nonalcoholic fatty liver disease. In part, this epidemic is fueled by the increasing consumption of caloric sweeteners coupled with an innate capacity to convert sugar into fat via hepati... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "glucose",
"start": 1154,
"end": 1161
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "fructose",
"start": 1331,
"end": 1339
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "uric acid",
"start": 1394,
"end": 1403... | [
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T14",
"arg2": "T33"
},
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T14",
"arg2": "T34"
},
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T14",
"arg2": "T35"
},
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T14",
"... |
17292977 | Biological activity of AC3174, a peptide analog of exendin-4. | Exenatide, the active ingredient of BYETTA (exenatide injection), is an incretin mimetic that has been developed for the treatment of patients with type 2 diabetes. Exenatide binds to and activates the known GLP-1 receptor with a potency comparable to that of the mammalian incretin GLP-1(7-36), thereby acting as a gluc... | Biological activity of AC3174, a peptide analog of exendin-4. Exenatide, the active ingredient of BYETTA (exenatide injection), is an incretin mimetic that has been developed for the treatment of patients with type 2 diabetes. Exenatide binds to and activates the known GLP-1 receptor with a potency comparable to that o... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "glucose",
"start": 1073,
"end": 1080
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "glucose",
"start": 1161,
"end": 1168
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "glucose",
"start": 1424,
"end": 1431
... | [
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T3",
"arg2": "T11"
}
] |
23348500 | A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling. | Metabotropic glutamate receptor 5 (mGlu5) is a target for the treatment of central nervous system (CNS) disorders, such as schizophrenia and Alzheimer's disease. Furthermore, mGlu5 has been shown to play an important role in hippocampal synaptic plasticity, specifically in long-term depression (LTD) and long-term poten... | A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling. Metabotropic glutamate receptor 5 (mGlu5) is a target for the treatment of central nervous system (CNS) disorders, such as schizophrenia and Alzheimer's disease. Furthermore, mGlu5... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "NCFP",
"start": 1192,
"end": 1196
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "CPPHA",
"start": 1210,
"end": 1215
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "NCFP",
"start": 1320,
"end": 1324
},
{
... | [
{
"type": "PART-OF",
"arg1": "T8",
"arg2": "T27"
},
{
"type": "PART-OF",
"arg1": "T9",
"arg2": "T27"
},
{
"type": "DIRECT-REGULATOR",
"arg1": "T11",
"arg2": "T29"
},
{
"type": "DIRECT-REGULATOR",
"arg1": "T10",
"arg2": "T29"
},
{
"type": "DIRECT-RE... |
7828655 | Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra. | To study the influence of dopaminergic activity on the expression of dopamine D2 receptors and glutamic acid decarboxylase in substantia nigra, mice were treated daily for several days with an irreversibly acting dopamine D1 and dopamine D2 receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) or wi... | Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra. To study the influence of dopaminergic activity on the expression of dopamine D2 receptors and glutamic acid decarboxylase in substantia nigra, mice were treated daily for several days with an irre... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "dopamine",
"start": 1163,
"end": 1171
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "dopamine",
"start": 1210,
"end": 1218
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "dopamine",
"start": 1285,
"end": 1293... | [
{
"type": "ANTAGONIST",
"arg1": "T11",
"arg2": "T40"
},
{
"type": "ANTAGONIST",
"arg1": "T12",
"arg2": "T40"
},
{
"type": "ANTAGONIST",
"arg1": "T11",
"arg2": "T39"
},
{
"type": "ANTAGONIST",
"arg1": "T12",
"arg2": "T39"
},
{
"type": "ANTAGONIST",
... |
15456329 | Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. | Nabumetone is a nonsteroidal anti-inflammatory prodrug, which exerts its pharmacological effects via the metabolite 6-methoxy-2-naphthylacetic acid (6-MNA). Nabumetone itself is non-acidic and, following absorption, it undergoes extensive first-pass metabolism to form the main circulating active metabolite (6-MNA) whic... | Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. Nabumetone is a nonsteroidal anti-inflammatory prodrug, which exerts its pharmacological effects via the metabolite 6-methoxy-2-naphthylacetic acid (6-MNA). Nabumetone itself is non-acidic and, following absorpt... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Nabumetone",
"start": 109,
"end": 119
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "nabumetone",
"start": 1203,
"end": 1213
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "6-methoxy-2-naphthylacetic acid",
"star... | [
{
"type": "INHIBITOR",
"arg1": "T19",
"arg2": "T36"
},
{
"type": "INHIBITOR",
"arg1": "T13",
"arg2": "T36"
},
{
"type": "INHIBITOR",
"arg1": "T15",
"arg2": "T33"
},
{
"type": "INHIBITOR",
"arg1": "T15",
"arg2": "T34"
},
{
"type": "INHIBITOR",
"... |
17258485 | Vitamin C transport and SVCT1 transporter expression in chick renal proximal tubule cells in culture. | The characteristics of vitamin C (ascorbic acid, ASC) transport were studied in polarized cultured monolayers of the chick (Gallus gallus) renal proximal tubule in Ussing chambers. Under voltage clamp conditions, monolayers responded to apical addition of ASC in a dose-dependent manner, with positive short circuit curr... | Vitamin C transport and SVCT1 transporter expression in chick renal proximal tubule cells in culture. The characteristics of vitamin C (ascorbic acid, ASC) transport were studied in polarized cultured monolayers of the chick (Gallus gallus) renal proximal tubule in Ussing chambers. Under voltage clamp conditions, monol... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "EIPA",
"start": 1122,
"end": 1126
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "sodium",
"start": 1162,
"end": 1168
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "chloride",
"start": 1243,
"end": 1251
},
... | [
{
"type": "INHIBITOR",
"arg1": "T4",
"arg2": "T31"
},
{
"type": "INHIBITOR",
"arg1": "T5",
"arg2": "T31"
},
{
"type": "INHIBITOR",
"arg1": "T25",
"arg2": "T29"
},
{
"type": "INHIBITOR",
"arg1": "T26",
"arg2": "T29"
},
{
"type": "INHIBITOR",
"ar... |
23545568 | Stable and high-rate overcharge protection for rechargeable lithium batteries. | Rechargeable lithium or lithium-ion cells can be overcharge-protected by an electroactive polymer composite separator. The use of non-woven fibrous membranes instead of conventional microporous membranes as the composite substrates allowed better distribution of the electroactive polymer, which led to improved utilizat... | Stable and high-rate overcharge protection for rechargeable lithium batteries. Rechargeable lithium or lithium-ion cells can be overcharge-protected by an electroactive polymer composite separator. The use of non-woven fibrous membranes instead of conventional microporous membranes as the composite substrates allowed b... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "lithium",
"start": 92,
"end": 99
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "lithium",
"start": 103,
"end": 110
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "LiNi1",
"start": 586,
"end": 591
},
{
... | [] |
23152189 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation. | Chloracne is commonly observed in humans exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); yet, the mechanism of toxicity is not well understood. Using normal human epidermal keratinocytes, we investigated the mechanism of TCDD-mediated enhancement of epidermal differentiation by integrating functional genomic, me... | 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation. Chloracne is commonly observed in humans exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); yet, the mechanism of toxicity is not well ... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "GSH",
"start": 1185,
"end": 1188
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "glutathione disulfide",
"start": 1189,
"end": 1210
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "TCDD",
"start": 1235,
"end": ... | [
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T20",
"arg2": "T34"
},
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T20",
"arg2": "T35"
},
{
"type": "INHIBITOR",
"arg1": "T3",
"arg2": "T36"
}
] |
7981624 | Annexin 1 regulation in human epidermal cells. | Annexin 1 (named p35, lipocortin I or calpactin II), initially described as a glucocorticoid induced protein, belongs to a new characterized family of intracellular proteins. In the skin, the role of annexins has still not been elucidated. In a previous study, we reported the localization of annexin 1 in both freshly i... | Annexin 1 regulation in human epidermal cells. Annexin 1 (named p35, lipocortin I or calpactin II), initially described as a glucocorticoid induced protein, belongs to a new characterized family of intracellular proteins. In the skin, the role of annexins has still not been elucidated. In a previous study, we reported ... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Ca2+",
"start": 1497,
"end": 1501
},
{
"id": "T2",
"type": "GENE-Y",
"text": "Annexin 1",
"start": 47,
"end": 56
},
{
"id": "T3",
"type": "GENE-Y",
"text": "annexin 1",
"start": 1102,
"end": 1111
},
{
... | [] |
11607047 | A review of the pharmacological and clinical profile of mirtazapine. | The novel antidepressant mirtazapine has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors. It enhances, therefore, the release of norepin... | A review of the pharmacological and clinical profile of mirtazapine. The novel antidepressant mirtazapine has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "mirtazapine",
"start": 1090,
"end": 1101
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "mirtazapine",
"start": 1161,
"end": 1172
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "amitriptyline",
"start": 1286,
... | [] |
12512695 | Vascular effects of COX inhibition and AT1 receptor blockade in transgenic rats harboring mouse renin-2 gene. | Ang II-induced endothelial dysfunction is associated with perivascular inflammation and increased superoxide production in the vascular wall. The present study examined the role of cyclo-oxygenase (COX)-synthetized eicosanoids in the pathogenesis of Ang II-induced endothelial dysfunction in transgenic rats harboring mo... | Vascular effects of COX inhibition and AT1 receptor blockade in transgenic rats harboring mouse renin-2 gene. Ang II-induced endothelial dysfunction is associated with perivascular inflammation and increased superoxide production in the vascular wall. The present study examined the role of cyclo-oxygenase (COX)-synthet... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Ang II",
"start": 110,
"end": 116
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "NO",
"start": 1265,
"end": 1267
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "NO",
"start": 1303,
"end": 1305
},
{
"i... | [
{
"type": "PRODUCT-OF",
"arg1": "T11",
"arg2": "T28"
},
{
"type": "PRODUCT-OF",
"arg1": "T11",
"arg2": "T31"
}
] |
23237733 | Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. | Isoliquiritigenin, a herbal ingredient with chalcone structure, has been speculated to be able to inhibit one of the most drug-metabolizing enzymes (DMEs) UDP-glucuronosyltransferase (UGT). Therefore, the aim of the present study was to investigate the inhibition of isoliquiritigenin towards important UGT isoforms in t... | Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. Isoliquiritigenin, a herbal ingredient with chalcone structure, has been speculated to be able to inhibit one of the most drug-metabolizing enzymes (DMEs)... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Isoliquiritigenin",
"start": 166,
"end": 183
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "isoliquiritigenin",
"start": 1369,
"end": 1386
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "isoliquiritigenin",
"star... | [
{
"type": "INHIBITOR",
"arg1": "T12",
"arg2": "T35"
},
{
"type": "INHIBITOR",
"arg1": "T12",
"arg2": "T36"
},
{
"type": "SUBSTRATE",
"arg1": "T13",
"arg2": "T35"
},
{
"type": "SUBSTRATE",
"arg1": "T13",
"arg2": "T36"
},
{
"type": "SUBSTRATE",
"... |
23361305 | Left ventricular noncompaction (LVNC) and low mitochondrial membrane potential are specific for Barth syndrome. | Barth syndrome (BTHS) is an X-linked mitochondrial defect characterised by dilated cardiomyopathy, neutropaenia and 3-methylglutaconic aciduria (3-MGCA). We report on two affected brothers with c.646G > A (p.G216R) TAZ gene mutations. The pathogenicity of the mutation, as indicated by the structure-based functional ana... | Left ventricular noncompaction (LVNC) and low mitochondrial membrane potential are specific for Barth syndrome. Barth syndrome (BTHS) is an X-linked mitochondrial defect characterised by dilated cardiomyopathy, neutropaenia and 3-methylglutaconic aciduria (3-MGCA). We report on two affected brothers with c.646G > A (p.... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "ATP",
"start": 1521,
"end": 1524
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "monolysocardiolipin",
"start": 473,
"end": 492
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "cardiolipin",
"start": 493,
"end"... | [] |
9353417 | Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. | The RNase Protection Assay was used to examine the regulation of D2 and D4 dopamine receptor mRNAs in the cerebral cortex and neostriatum of nonhuman primates after chronic treatment with a wide spectrum of antipsychotic medications (chlorpromazine, clozapine, haloperidol, molindone, olanzapine, pimozide, remoxipride a... | Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. The RNase Protection Assay was used to examine the regulation of D2 and D4 dopamine receptor mRNAs in the cerebral cortex and neostriat... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "tiapride",
"start": 1234,
"end": 1242
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "chlorpromazine",
"start": 1339,
"end": 1353
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "haloperidol",
"start": 1358,
"e... | [
{
"type": "ANTAGONIST",
"arg1": "T22",
"arg2": "T34"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T23",
"arg2": "T37"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T2",
"arg2": "T28"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T3",
"arg2": "T28"
},
... |
14585280 | Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. | DNA methylation abnormalities have recently emerged as one of the most frequent molecular changes in hematopoietic neoplasms. Since methylation and transcriptional status are inversely correlated, the hypermethylation of genes involved in cell-cycle control and apoptosis could have a pathogenetic role in the developmen... | Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. DNA methylation abnormalities have recently emerged as one of the most frequent molecular changes in hematopoietic neoplasms. Since methylation and transcriptional status are inversely correlated, the hypermethylation of genes involve... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "5-azacytidine",
"start": 1132,
"end": 1145
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "Decitabine",
"start": 1150,
"end": 1160
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "Azacytidine",
"start": 1268,
"... | [
{
"type": "INHIBITOR",
"arg1": "T1",
"arg2": "T9"
},
{
"type": "INHIBITOR",
"arg1": "T2",
"arg2": "T9"
},
{
"type": "INHIBITOR",
"arg1": "T5",
"arg2": "T10"
},
{
"type": "INHIBITOR",
"arg1": "T6",
"arg2": "T10"
}
] |
23211364 | AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. | Candesartan is an angiotensin II type 1 receptor blocker (ARB) that has been to shown to limit ischemic stroke and improve stroke outcome. In experimental stroke, candesartan induces a proangiogenic effect that is partly attributable to vascular endothelial growth factor. Brain-derived neurotrophic factor (BDNF) is a m... | AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Candesartan is an angiotensin II type 1 receptor blocker (ARB) that has been to shown to limit ischemic stroke and improve stroke outcome. In experimental stroke, candesartan induces a proangiogenic effect that is partly attributable to vascu... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Candesartan",
"start": 78,
"end": 89
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "Candesartan",
"start": 1134,
"end": 1145
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "candesartan",
"start": 1229,
"end":... | [
{
"type": "INHIBITOR",
"arg1": "T1",
"arg2": "T21"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T2",
"arg2": "T12"
},
{
"type": "ANTAGONIST",
"arg1": "T5",
"arg2": "T15"
}
] |
23624810 | Antiaggressive activity of central oxytocin in male rats. | RATIONALE: A substantial body of research suggests that the neuropeptide oxytocin promotes social affiliative behaviors in a wide range of animals including humans. However, its antiaggressive action has not been unequivocally demonstrated in male laboratory rodents. OBJECTIVE: Our primary goal was to examine the putat... | Antiaggressive activity of central oxytocin in male rats. RATIONALE: A substantial body of research suggests that the neuropeptide oxytocin promotes social affiliative behaviors in a wide range of animals including humans. However, its antiaggressive action has not been unequivocally demonstrated in male laboratory rod... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "oxytocin",
"start": 1198,
"end": 1206
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "oxytocin",
"start": 1382,
"end": 1390
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "oxytocin",
"start": 1780,
"end": 1788... | [] |
10626836 | Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes. | Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant and suggested that lithium might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and ... | Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes. Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant and suggested that lithium mig... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "AMPA",
"start": 1101,
"end": 1105
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "lithium",
"start": 1166,
"end": 1173
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "lithium",
"start": 219,
"end": 226
},
... | [
{
"type": "ACTIVATOR",
"arg1": "T3",
"arg2": "T23"
},
{
"type": "ACTIVATOR",
"arg1": "T13",
"arg2": "T28"
},
{
"type": "ACTIVATOR",
"arg1": "T2",
"arg2": "T18"
},
{
"type": "ACTIVATOR",
"arg1": "T5",
"arg2": "T20"
},
{
"type": "ACTIVATOR",
"arg... |
23536522 | The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats. | The present study aimed to compare the effect of gender difference on hemodynamic consequences in the development of monocrotaline (MCT)-induced pulmonary hypertension in rat. The effect of antioxidant enzyme systems on the development of pulmonary hypertension mediated by the phytotoxin MCT and the effect of gender on... | The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats. The present study aimed to compare the effect of gender difference on hemodynamic consequences in the development of monocrotaline (MCT)-induced pulmonary hypertension in rat. The effect of antioxidant enzyme systems on the develo... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "GSH",
"start": 1172,
"end": 1175
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "monocrotaline",
"start": 207,
"end": 220
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "MCT",
"start": 222,
"end": 225
},
{... | [
{
"type": "INHIBITOR",
"arg1": "T14",
"arg2": "T25"
},
{
"type": "INHIBITOR",
"arg1": "T14",
"arg2": "T26"
},
{
"type": "ACTIVATOR",
"arg1": "T14",
"arg2": "T27"
}
] |
23198810 | Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1. | Achieving the vision of identifying and quantifying cancer-related events and targets for future personalized oncology is predicated on the existence of synthetically accessible and economically viable probe molecules fully able to report the presence of these events and targets in a rapid and highly selective and sens... | Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1. Achieving the vision of identifying and quantifying cancer-related events and targets for future personalized oncology is predicated on the existence of synthetically accessibl... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "quinone",
"start": 1149,
"end": 1156
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "quinone",
"start": 1206,
"end": 1213
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "naphthalimide",
"start": 840,
"end": 85... | [
{
"type": "SUBSTRATE",
"arg1": "T1",
"arg2": "T6"
},
{
"type": "SUBSTRATE",
"arg1": "T1",
"arg2": "T7"
}
] |
11426832 | Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. | The organic anion transport system is involved in the tubular excretion of various clinically important drugs. The purpose of this study was to characterize the effects of various organic anion transport inhibitors on organic anion transport using proximal tubule cells stably expressing human organic anion transporter ... | Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. The organic anion transport system is involved in the tubular excretion of various clinically important drugs. The purpose of this study was to characterize the effects of various organic anion transpo... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "cilastatin",
"start": 1187,
"end": 1197
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "KW-3902",
"start": 1255,
"end": 1262
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "KW-3902",
"start": 1314,
"end": 1321... | [
{
"type": "INHIBITOR",
"arg1": "T7",
"arg2": "T19"
},
{
"type": "INHIBITOR",
"arg1": "T4",
"arg2": "T19"
},
{
"type": "INHIBITOR",
"arg1": "T5",
"arg2": "T19"
},
{
"type": "INHIBITOR",
"arg1": "T6",
"arg2": "T19"
},
{
"type": "INHIBITOR",
"arg1... |
10047461 | Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. | Tomudex (ZD1694) is a specific antifolate-based thymidylate synthase inhibitor active in a variety of solid tumor malignancies. Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of thymidylate synthase by Tomudex. Twenty-four h... | Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Tomudex (ZD1694) is a specific antifolate-based thymidylate synthase inhibitor active in a variety of solid tumor malignancies. Studies were carried out in vitro to eval... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Tomudex",
"start": 151,
"end": 158
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "Tomudex",
"start": 1697,
"end": 1704
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "thymidylate",
"start": 1805,
"end": 1816
... | [
{
"type": "INHIBITOR",
"arg1": "T16",
"arg2": "T62"
},
{
"type": "INHIBITOR",
"arg1": "T1",
"arg2": "T50"
},
{
"type": "INHIBITOR",
"arg1": "T10",
"arg2": "T46"
},
{
"type": "INDIRECT-DOWNREGULATOR",
"arg1": "T13",
"arg2": "T54"
},
{
"type": "INDIR... |
9950599 | Oxidative stress induces differential gene expression in a human lens epithelial cell line. | PURPOSE: To identify differentially expressed genes in a human lens epithelial cell line exposed to oxidative stress. METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR) differential display was used to evaluate differential gene expression in a human lens epithelial cell line (SRA 01-04) when cells were ... | Oxidative stress induces differential gene expression in a human lens epithelial cell line. PURPOSE: To identify differentially expressed genes in a human lens epithelial cell line exposed to oxidative stress. METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR) differential display was used to evaluate di... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "beta-hydroxyisobutyryl",
"start": 1101,
"end": 1123
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "coenzyme A",
"start": 1124,
"end": 1134
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "NADH",
"start": 1265,
... | [] |
18480678 | Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? | d,l-threo-methylphenidate (MPH) is an effective first-line treatment for the symptoms associated with attention-deficit/hyperactivity disorder. threo-methylphenidate inhibits the dopamine transporter and the norepinephrine transporter, resulting in elevations of these monoamines after impulse release. Although MPH has ... | Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? d,l-threo-methylphenidate (MPH) is an effective first-line treatment for the symptoms associated with attention-deficit/hyperactivity disorder. threo-methylphenidate inhibits the dopamine transporter and the norepi... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "d,l-threo-methylphenidate",
"start": 106,
"end": 131
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "d-MPH",
"start": 1117,
"end": 1122
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "l-MPH",
"start": 1132,
"e... | [
{
"type": "INHIBITOR",
"arg1": "T8",
"arg2": "T30"
},
{
"type": "INHIBITOR",
"arg1": "T8",
"arg2": "T31"
},
{
"type": "SUBSTRATE",
"arg1": "T17",
"arg2": "T30"
},
{
"type": "SUBSTRATE",
"arg1": "T17",
"arg2": "T31"
},
{
"type": "DIRECT-REGULATOR",
... |
8697470 | [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. | The extrinsic coagulation pathway is activated when tissue factor (TF) is exposed as a consequence of arterial damage. TF binds to factor VII (FVII) or activated FVII (FVIIa), generating a complex that activates both FX and FIX, ultimately leading to thrombin formation. To determine whether inhibition of FVII binding t... | [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. The extrinsic coagulation pathway is activated when tissue factor (TF) is exposed as a consequence of arterial damage. TF binds to factor VII (FVII) or activated FVII (FVIIa), generating a co... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "aurintrycarboxilic acid",
"start": 1686,
"end": 1709
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "ATA",
"start": 1711,
"end": 1714
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "ATA",
"start": 2215,
"end":... | [
{
"type": "INHIBITOR",
"arg1": "T2",
"arg2": "T14"
},
{
"type": "INHIBITOR",
"arg1": "T1",
"arg2": "T14"
},
{
"type": "INHIBITOR",
"arg1": "T1",
"arg2": "T15"
},
{
"type": "INHIBITOR",
"arg1": "T2",
"arg2": "T15"
}
] |
23323829 | Design and application of anthracene derivative with aggregation-induced emission charateristics for visualization and monitoring of erythropoietin unfolding. | Erythropoietin (EPO) is an attractive protein-unfolding/folding model because of its high degree of unfolding and folding reversibility and intermediate size. Due to its function for regulating red blood cell production by stimulating late erythroid precursor cells, EPO presents obvious values to biological research. A... | Design and application of anthracene derivative with aggregation-induced emission charateristics for visualization and monitoring of erythropoietin unfolding. Erythropoietin (EPO) is an attractive protein-unfolding/folding model because of its high degree of unfolding and folding reversibility and intermediate size. Du... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "anthracene",
"start": 492,
"end": 502
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "9,10-bis[4-(3-sulfonatopropoxyl)-styryl]anthracene sodium salt",
"start": 523,
"end": 585
},
{
"id": "T3",
"type": "CHEMICAL",
"t... | [
{
"type": "DIRECT-REGULATOR",
"arg1": "T6",
"arg2": "T17"
},
{
"type": "DIRECT-REGULATOR",
"arg1": "T7",
"arg2": "T10"
}
] |
23404739 | Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion. | Sipholenol A, a sipholane triterpene isolated from the Red Sea sponge Callyspongia siphonella, has the ability to reverse multidrug resistance in cancer cells that overexpress P-glycoprotein (P-gp). Here, the antimigratory activity of sipholenol A and analogues are reported against the highly metastatic human breast ca... | Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion. Sipholenol A, a sipholane triterpene isolated from the Red Sea sponge Callyspongia siphonella, has the ability to reverse multidrug resistance in cancer cells that overexpress P-glycoprotein (P-gp). Here, the antimigrat... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Sipholenol A",
"start": 101,
"end": 113
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "carbamate",
"start": 1164,
"end": 1173
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "19,20-anhydrosipholenol A 4β-benzoate este... | [
{
"type": "DIRECT-REGULATOR",
"arg1": "T3",
"arg2": "T25"
},
{
"type": "DIRECT-REGULATOR",
"arg1": "T3",
"arg2": "T26"
},
{
"type": "INHIBITOR",
"arg1": "T5",
"arg2": "T28"
},
{
"type": "INHIBITOR",
"arg1": "T6",
"arg2": "T29"
},
{
"type": "INHIBIT... |
23258671 | Super-stable ultrafine beta-tungsten nanocrystals with metastable phase and related magnetism. | Ultrafine tungsten nanocrystals (average size of 3 nm) with a metastable phase (beta-tungsten with A15 structure, β-W) have been prepared by laser ablation of tungsten in liquid nitrogen. The as-prepared metastable nanocrystals exhibited super-stablity, and can keep the same metastable structure over a period of 6 mont... | Super-stable ultrafine beta-tungsten nanocrystals with metastable phase and related magnetism. Ultrafine tungsten nanocrystals (average size of 3 nm) with a metastable phase (beta-tungsten with A15 structure, β-W) have been prepared by laser ablation of tungsten in liquid nitrogen. The as-prepared metastable nanocrysta... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "tungsten",
"start": 105,
"end": 113
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "W",
"start": 211,
"end": 212
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "tungsten",
"start": 254,
"end": 262
},
{
... | [] |
10403635 | Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. | The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (AChE) in the nervous system, which leads to increased synaptic acetylcholine levels. The protective actions of intravenously (i.v.) administered pyridostigmine, physostigmine, eptastigmine, ... | Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (AChE) in the nervous system, which leads to increased synaptic acetylcho... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "Physostigmine",
"start": 1162,
"end": 1175
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "carbamate",
"start": 1199,
"end": 1208
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "sarin",
"start": 1212,
"end": 1... | [
{
"type": "INHIBITOR",
"arg1": "T20",
"arg2": "T40"
},
{
"type": "INHIBITOR",
"arg1": "T20",
"arg2": "T42"
},
{
"type": "SUBSTRATE",
"arg1": "T16",
"arg2": "T40"
},
{
"type": "SUBSTRATE",
"arg1": "T16",
"arg2": "T42"
},
{
"type": "INHIBITOR",
"... |
23585380 | Dual Growth Factor Delivery Using Biocompatible Core-Shell Microcapsules for Angiogenesis. | An optimized electrodropping system produces homogeneous core-shell microcapsules (C-S MCs) by using poly(L-lactic-co-glycolic acid) (PLGA) and alginate. Fluorescence imaging clearly shows the C-S domain in the MC. For release control, the use of high-molecular-weight PLGA (HMW 270 000) restrains the initial burst rele... | Dual Growth Factor Delivery Using Biocompatible Core-Shell Microcapsules for Angiogenesis. An optimized electrodropping system produces homogeneous core-shell microcapsules (C-S MCs) by using poly(L-lactic-co-glycolic acid) (PLGA) and alginate. Fluorescence imaging clearly shows the C-S domain in the MC. For release co... | [
{
"id": "T1",
"type": "CHEMICAL",
"text": "poly(L-lactic-co-glycolic acid)",
"start": 192,
"end": 223
},
{
"id": "T2",
"type": "CHEMICAL",
"text": "PLGA",
"start": 1218,
"end": 1222
},
{
"id": "T3",
"type": "CHEMICAL",
"text": "PLGA",
"start": 1255,
... | [
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T2",
"arg2": "T14"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T2",
"arg2": "T8"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T3",
"arg2": "T14"
},
{
"type": "INDIRECT-UPREGULATOR",
"arg1": "T3",
"arg2": "T8"
... |
DrugProt (Parquet)
A clean, ready-to-use Parquet version of the DrugProt corpus from BioCreative VII Track 1, converted for seamless use with the Hugging Face datasets library.
DrugProt is a gold-standard corpus of 4,250 PubMed abstracts annotated for drug/chemical–protein interactions, covering 13 fine-grained relation types and 3 entity types. It is designed for training and evaluating biomedical relation extraction systems.
Quick Start
from datasets import load_dataset
dataset = load_dataset("OpenMed/drugprot-parquet")
# Access splits
train = dataset["train"] # 3,500 abstracts
val = dataset["validation"] # 750 abstracts
# Inspect a sample
example = train[0]
print(example["title"])
print(f"Entities: {len(example['entities'])}")
print(f"Relations: {len(example['relations'])}")
Dataset Description
Each example represents a PubMed abstract with expert-annotated entity spans and relation labels:
| Field | Type | Description |
|---|---|---|
pmid |
string |
PubMed article ID |
title |
string |
Article title |
abstract |
string |
Article abstract |
text |
string |
Full text (title + abstract) |
entities |
list[dict] |
Annotated entity spans |
relations |
list[dict] |
Annotated drug–protein relations |
Entity Schema
Each entity contains:
| Field | Type | Description |
|---|---|---|
id |
string |
Unique entity ID (e.g., T1, T2) |
type |
string |
Entity type: CHEMICAL, GENE-Y, or GENE-N |
text |
string |
Surface text of the entity mention |
start |
int |
Character offset (start) in text field |
end |
int |
Character offset (end) in text field |
Entity types:
- CHEMICAL — Drugs, small molecules, metabolites, and other chemical compounds
- GENE-Y — Gene/protein mentions that are a normalized, valid gene/protein
- GENE-N — Gene/protein mentions that are NOT normalized (e.g., protein families, complexes)
Relation Schema
Each relation contains:
| Field | Type | Description |
|---|---|---|
type |
string |
One of 13 relation categories (see below) |
arg1 |
string |
Entity ID of the first argument |
arg2 |
string |
Entity ID of the second argument |
Relation Types (13 Classes)
| Relation | Description | Train | Val |
|---|---|---|---|
INHIBITOR |
Chemical inhibits the protein | 5,388 | 1,150 |
DIRECT-REGULATOR |
Chemical directly regulates protein (mechanism unspecified) | 2,247 | 458 |
SUBSTRATE |
Chemical is a substrate of the enzyme | 2,003 | 494 |
ACTIVATOR |
Chemical activates the protein | 1,428 | 246 |
INDIRECT-UPREGULATOR |
Chemical indirectly increases protein activity/expression | 1,378 | 302 |
INDIRECT-DOWNREGULATOR |
Chemical indirectly decreases protein activity/expression | 1,329 | 332 |
ANTAGONIST |
Chemical acts as antagonist of the receptor/protein | 972 | 218 |
PRODUCT-OF |
Chemical is a product of the enzyme | 920 | 158 |
PART-OF |
Chemical is part of the protein complex | 885 | 257 |
AGONIST |
Chemical acts as agonist of the receptor/protein | 658 | 131 |
AGONIST-ACTIVATOR |
Chemical is both agonist and activator | 29 | 10 |
SUBSTRATE_PRODUCT-OF |
Chemical is both substrate and product | 24 | 3 |
AGONIST-INHIBITOR |
Chemical is agonist but inhibits downstream effects | 13 | 2 |
| Total | 17,274 | 3,761 |
Dataset Statistics
| Train | Validation | Total | |
|---|---|---|---|
| Abstracts | 3,500 | 750 | 4,250 |
| Abstracts with relations | 2,433 | — | — |
| Total entities | 89,529 | — | — |
| • CHEMICAL | 46,274 (51.7%) | — | — |
| • GENE-Y | 28,421 (31.7%) | — | — |
| • GENE-N | 14,834 (16.6%) | — | — |
| Total relations | 17,274 | 3,761 | 21,035 |
| Avg. entities / abstract | 25.6 | — | — |
| Avg. relations / abstract | 4.9 | — | — |
Usage Examples
Relation Extraction
from datasets import load_dataset
ds = load_dataset("OpenMed/drugprot-parquet", split="train")
for example in ds:
entities = {e["id"]: e for e in example["entities"]}
for rel in example["relations"]:
arg1 = entities[rel["arg1"]]
arg2 = entities[rel["arg2"]]
print(f"{arg1['text']} --[{rel['type']}]--> {arg2['text']}")
Named Entity Recognition (NER)
from datasets import load_dataset
ds = load_dataset("OpenMed/drugprot-parquet", split="train")
for example in ds:
text = example["text"]
for ent in example["entities"]:
span = text[ent["start"]:ent["end"]]
assert span == ent["text"], f"Offset mismatch: '{span}' != '{ent['text']}'"
print(f"[{ent['type']}] {ent['text']} ({ent['start']}:{ent['end']})")
Convert to Token Classification Format
from datasets import load_dataset
ds = load_dataset("OpenMed/drugprot-parquet", split="train")
# Build BIO tags from character offsets
example = ds[0]
text = example["text"]
char_labels = ["O"] * len(text)
for ent in sorted(example["entities"], key=lambda e: e["start"]):
tag = ent["type"]
char_labels[ent["start"]] = f"B-{tag}"
for i in range(ent["start"] + 1, ent["end"]):
char_labels[i] = f"I-{tag}"
Source
This dataset is a Parquet conversion of the DrugProt BioCreative VII corpus. The original data was released under CC BY 4.0 for the BioCreative VII shared task.
Original paper:
M. Krallinger, O. Rabal, A. Lourenco, J. Oyarzabal, A. Valencia.
"Overview of the BioCreative VII Track 1 – DrugProt: Drug-Protein Relation Extraction."
Proceedings of the BioCreative VII Challenge Evaluation Workshop, 2021.
BibTeX:
@inproceedings{drugprot2021,
title={Overview of the BioCreative VII Track 1 -- DrugProt: Drug-Protein Relation Extraction},
author={Krallinger, Martin and Rabal, Obdulia and Lourenco, Analia and Oyarzabal, Julen and Valencia, Alfonso},
booktitle={Proceedings of the BioCreative VII Challenge Evaluation Workshop},
year={2021}
}
License
CC BY 4.0 — following the original DrugProt corpus license.
About OpenMed
OpenMed provides clean, standardized biomedical datasets and RL training environments for medical AI research.
- Downloads last month
- 46